Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Rad takes hepatitis tests to the US and Canada:

This article was originally published in Clinica

Executive Summary

Bio-Rad Laboratories plans to launch two new hepatitis B tests in the US and in Canada shortly. The blood screening Genetic Systems HBsAg EIA 3.0 and the HBsAg confirmatory assay 3.0 are more sensitive and easier to use than Bio-Rad's existing hepatitis B kits, the Hercules, California company says. They are also the only hepatitis B tests to gain regulatory approval for use on cadaveric samples, or samples taken from organ donors, the firm adds.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061848

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel